Developed in collaboration with the CUHK spin-off MicroSigX Biotech Diagnostic, the world’s first “AI-Powered Multikingdom ...
Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback